SARS-CoV-2 vaccination and COVID-19 infections in people with multiple sclerosis treated with ocrelizumab in the prospective, multicenter, noninterventional MuSicalE and CONFIDENCE studies

  • M Trojano
  • , S Meuth
  • , M Buttmann
  • , MS Weber
  • , Pesch V Van
  • , R Alroughani
  • , A Rovira
  • , G Cutter
  • , J Hobart
  • , M Sierzega
  • , Q Wang
  • , L Craveiro
  • , D Dzhenkova
  • , J Eggebrecht
  • , EM-L Rouzic
  • , T Ziemssen

Research output: Contribution to conferenceConference paper (not formally published)peer-review

Original languageEnglish
DOIs
Publication statusPublished - Oct 2022

Cite this